1. OPUS at UTS

Browsing byAuthorKamal, MA

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 13 of 13< previous 
Issue DateTitleAuthor(s)
2017-01-01Inhibition of butyrylcholinesterase with fluorobenzylcymserine, an experimental Alzheimer’s drug candidate: Validation of enzoinformatics results by classical and innovative enzyme kinetic analysesKamal, MA; Shakil, S; Nawaz, MS; Yu, QS; Tweedie, D; Tan, Y; Qu, X; Greig, NH
2022-09-21Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic RegulationRahman, MM; Islam, MR; Mim, SA; Sultana, N; Chellappan, DK; Dua, K; Kamal, MA; Sharma, R; Emran, TB
2013-01Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats.Tan, Y; Lao, W; Xiao, L; Wang, Z; Xiao, W; Kamal, MA; Seale, JP; Qu, X
2022-03-27Mechanism of mesenchymal stem cells as a multitarget disease-modifying therapy for parkinson's disease.Unnisa, A; Dua, K; Kamal, MA
-Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthmaAllam, VSRR; Paudel, KR; Gupta, G; Singh, SK; Vishwas, S; Gulati, M; Gupta, S; Chaitanya, MVNL; Jha, NK; Gupta, PK; Patel, VK; Liu, G; Kamal, MA; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K
2011-12-01Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in miceTan, Y; Sun, LQ; Kamal, MA; Wang, X; Seale, JP; Qu, X
2009-12-01Targeting BuChE-inflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer diseaseKamal, MA; Tan, Y; Seale, JP; Qu, X
2008-06-01Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysisKamal, MA; Qu, X; Yu, QS; Tweedie, D; Holloway, HW; Li, Y; Tan, Y; Greig, NH
Showing results 6 to 13 of 13< previous